Skip to main content
Pharmafile

Is the Current EU Legal Framework for Orphan Medicines Fit for Purpose?

Autumn 2019
Authors
Maria Isabel ManleyDr. Chris Boyle

Maria Isabel Manley, partner and head of the UK Global Life Sciences Practice, and Chris Boyle, associate, at Sidley, discuss the impact of regulatory frameworks on medicines for rare diseases.

View Article

Contacts

Manley, Maria Isabel
合伙人律师
Boyle, Chris
合伙人律师

Capabilities

Suggested News & Insights

Recharge & Recaffeinate with Sidley @ JPMMonday, January 12, 2026 – Tuesday, January 13, 2026
活动
Biotech Dealmaking – Regulatory Considerations for the Next Wave of Development-Stage Transactions – Program and Lunch @ JPM 2026Monday, January 12, 2026
活动
Top 10 FDA Areas We Are Watching For 2026January 12, 2026
盛德动态
Sidley Advises on Market-Defining Cross-Border India Matters in 2025January 12, 2026
公告
Impact of U.S. FDA Warning Letters in Europe: Practical Considerations for IndustryJanuary 12, 2026
Food, Drug, and Medical Device Update
Sidley Represents Changchun GeneScience (GenSci) Pharmaceuticals in Its Strategic Licensing Agreement With Yarrow Bioscience for First-in-Class Autoimmune Thyroid Disease TherapyDecember 18, 2025
公告